000 | 03365cam a2200541Ii 4500 | ||
---|---|---|---|
001 | on1029740839 | ||
003 | OCoLC | ||
005 | 20221128213615.0 | ||
006 | m d | ||
007 | cr cn||||||||| | ||
008 | 180328s2019 paua obf 001 0 eng d | ||
040 |
_aLGG _beng _erda _epn _cLGG _dUAB _dOCLCO _dCASUM _dOCLCQ _dOCLCF _dOCLCA _dCUX _dN$T |
||
019 | _a1039687034 | ||
020 |
_a9781496367099 _q(electronic bk.) |
||
020 |
_a149636709X _q(electronic bk.) |
||
020 | _z1496347447 | ||
020 | _z9781496347442 | ||
035 |
_a2112278 _b(N$T) |
||
035 |
_a(OCoLC)1029740839 _z(OCoLC)1039687034 |
||
060 | 4 | _aWD 101 | |
072 | 7 |
_aHEA _x039000 _2bisacsh |
|
072 | 7 |
_aMED _x014000 _2bisacsh |
|
072 | 7 |
_aMED _x022000 _2bisacsh |
|
072 | 7 |
_aMED _x112000 _2bisacsh |
|
072 | 7 |
_aMED _x045000 _2bisacsh |
|
049 | _aMAIN | ||
130 | 0 | _aDyslipidemia (Myerson) | |
245 | 1 | 0 |
_aDyslipidemia : _ba clinical approach _c _h[E-Book] |
263 | _a1712 | ||
264 | 1 |
_aPhiladelphia : _bWolters Kluwer, _c[2019] |
|
300 |
_a1 online resource : _billustrations |
||
336 |
_atext _2rdacontent |
||
337 |
_acomputer _2rdamedia |
||
338 |
_aonline resource _2rdacarrier |
||
588 | _aDescription based on print version record. | ||
504 | _aIncludes bibliographical references and index. | ||
520 | _a"Dyslipidemia: A Clinical Approach is intended as a low-cost, quick-reference, easy-to-navigate guide for a broad range of healthcare professionals that will provide high-yield decision-making tools to ensure confidence in patient treatment and management of those who are suffering from a lipids disorder or related disease. Content will include detailed drug tables, information on important drug interactions, and also non-statin alternatives for those patients who cannot tolerate statins. In addition, decision-making algorithms and careful patient management plans will be included to ensure quicker and more effective treatment and management of patients"--Provided by publisher. | ||
505 | 0 | _a1. A historical perspectives on lipids and cardiovascular disease -- 2. Basic lipid and lipoprotein biochemistry for clinical lipidologists -- 3. Guidelines and risk scores -- 4. Lipid measurement -- 5. Step-by-step diagnosis and management plan -- 6. Lifestyle modification in the management of dyslipidemia -- 7. Lipid medications overview: prescription and nonprescription preparations -- 8. Statins -- 9. Nonstain medications: omega-3 fatty acids, fibrates, bile acid sequestrants, niacin, and cholesterol absorption inhibitors -- 10. Hypertriglyceridemia -- 11. Safety and tolerability of lipid-lowering medications -- 12. Familial hypercholesterolemia: family disease -- 13. Complex dyslipidemias -- 14. Children and adolescents step-by-step evaluation and management plan -- 15. Lipid management in special populations. | |
590 | _aAdded to collection customer.56279.3 | ||
650 | 1 | 2 |
_aDyslipidemias _xdiagnosis. |
650 | 2 | 2 |
_aDyslipidemias _xtherapy. |
650 | 0 |
_aLipids _xMetabolism _xDisorders. |
|
700 | 1 |
_aMyerson, Merle, _eeditor. |
|
856 | 4 | 0 |
_uhttps://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=2112278 _yKingston Hospital NHS Foundation Trust OpenAthens account holders click here for access |
938 |
_aEBSCOhost _bEBSC _n2112278 |
||
942 | _n0 | ||
994 |
_a92 _bN$T |
||
999 |
_c93293 _d93293 |